Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,035,082
-
Share change
-
+9,817,541
-
Total reported value
-
$16,822,135
-
Put/Call ratio
-
15%
-
Price per share
-
$0.56
-
Number of holders
-
51
-
Value change
-
+$5,007,578
-
Number of buys
-
20
-
Number of sells
-
21
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q4 2021
As of 31 Dec 2021 ACELRX PHARMACEUTICALS INC - COM (ACRX) had 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,035,082 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, Rock Springs Capital Management LP, VANGUARD GROUP INC, D. E. Shaw & Co., Inc., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Values First Advisors, Inc., STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This table shows 51 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.